Mesoblast price target raised to $24 from $15 at Piper Sandler
Piper Sandler analyst Edward Tenthoff raised the firm’s price target on Mesoblast (MESO) to $24 from $15 and keeps an Overweight rating on the ...
Piper Sandler Remains a Buy on Mesoblast (MESO)
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Mesoblast (MESO – Research Report) today and set a price target of $24.00. The ...